Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Genpact Limited stock logo
G
Genpact
$31.66
+0.4%
$33.35
$29.41
$44.83
$5.71B1.071.50 million shs909,569 shs
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
$1.38
+0.7%
$1.54
$0.78
$2.70
$1.39B1.112.89 million shs8.67 million shs
R1 RCM Inc. stock logo
RCM
R1 RCM
$11.75
-1.3%
$12.78
$8.87
$18.70
$4.94B0.783.69 million shs1.91 million shs
These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Genpact Limited stock logo
G
Genpact
-0.13%+2.97%-1.04%-13.23%-29.40%
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
+4.20%-1.44%-15.22%-0.36%-38.79%
R1 RCM Inc. stock logo
RCM
R1 RCM
-0.67%-3.41%-8.38%+14.19%-24.19%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Genpact Limited stock logo
G
Genpact
3.8518 of 5 stars
3.03.03.30.02.41.72.5
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
2.8863 of 5 stars
2.91.00.03.21.23.30.0
R1 RCM Inc. stock logo
RCM
R1 RCM
4.568 of 5 stars
4.33.00.03.61.34.20.6

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Genpact Limited stock logo
G
Genpact
2.00
Hold$39.7825.64% Upside
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
1.80
Reduce$1.8131.64% Upside
R1 RCM Inc. stock logo
RCM
R1 RCM
2.62
Moderate Buy$16.8743.55% Upside

Current Analyst Ratings

Latest LUMN, G, and RCM Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/22/2024
Genpact Limited stock logo
G
Genpact
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$36.00 ➝ $33.00
4/10/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$20.00
4/10/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
KeyCorp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Sector Weight
4/5/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Guggenheim
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $15.00
4/1/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingHold ➝ Hold$16.00
3/26/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$17.00
3/20/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$17.00 ➝ $16.00
3/20/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeNeutral ➝ Buy$16.00
3/7/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$19.00
3/5/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$20.00
3/5/2024
R1 RCM Inc. stock logo
RCM
R1 RCM
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Hold$16.00
(Data available from 4/23/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Genpact Limited stock logo
G
Genpact
$4.48B1.28$3.13 per share10.10$12.40 per share2.55
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
$14.56B0.10$3.27 per share0.42$0.41 per share3.35
R1 RCM Inc. stock logo
RCM
R1 RCM
$2.25B2.19$0.67 per share17.50$6.56 per share1.79

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Genpact Limited stock logo
G
Genpact
$631.26M$3.439.2310.881.4914.10%23.19%10.23%5/9/2024 (Confirmed)
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
-$10.30B-$10.47N/AN/AN/A-70.74%4.85%0.51%4/30/2024 (Confirmed)
R1 RCM Inc. stock logo
RCM
R1 RCM
$3.30MN/A0.0078.33N/A0.15%0.12%0.07%5/8/2024 (Confirmed)

Latest LUMN, G, and RCM Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/9/2024N/A
Genpact Limited stock logo
G
Genpact
$0.62N/A-$0.62N/AN/AN/A  
5/8/2024N/A
R1 RCM Inc. stock logo
RCM
R1 RCM
-$0.05N/A+$0.05N/AN/AN/A  
4/30/2024N/A
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
-$0.0350N/A+$0.0350N/AN/AN/A  
2/8/2024Q4 2023
Genpact Limited stock logo
G
Genpact
$0.65$0.68+$0.03-$0.23$1.12 billion$1.15 billion
2/6/2024Q4 2023
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
-$0.03$0.08+$0.11$2.19$3.45 billion$3.52 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Genpact Limited stock logo
G
Genpact
$0.611.93%+12.14%17.78%7 Years
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
N/AN/AN/AN/AN/A
R1 RCM Inc. stock logo
RCM
R1 RCM
N/AN/AN/AN/AN/A

Latest LUMN, G, and RCM Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/8/2024
Genpact Limited stock logo
G
Genpact
Quarterly$0.15301.68%3/8/20243/11/20243/26/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Genpact Limited stock logo
G
Genpact
0.37
1.44
1.44
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
47.56
1.35
1.35
R1 RCM Inc. stock logo
RCM
R1 RCM
0.57
1.83
1.83

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Genpact Limited stock logo
G
Genpact
96.03%
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
66.19%
R1 RCM Inc. stock logo
RCM
R1 RCM
61.10%

Insider Ownership

CompanyInsider Ownership
Genpact Limited stock logo
G
Genpact
2.80%
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
1.68%
R1 RCM Inc. stock logo
RCM
R1 RCM
36.80%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Genpact Limited stock logo
G
Genpact
129,100180.33 million175.28 millionOptionable
Lumen Technologies, Inc. stock logo
LUMN
Lumen Technologies
28,0001.01 billion992.79 millionOptionable
R1 RCM Inc. stock logo
RCM
R1 RCM
30,000420.73 million265.90 millionOptionable

LUMN, G, and RCM Headlines

SourceHeadline
4 RCM companies making executive moves4 RCM companies making executive moves
beckershospitalreview.com - April 24 at 12:05 AM
Medical Billing Outsourcing Market to USD 41.9Bn by 2032, says Global Market Insights Inc.Medical Billing Outsourcing Market to USD 41.9Bn by 2032, says Global Market Insights Inc.
finance.yahoo.com - April 23 at 7:05 PM
Arkansas systems payer strategy sparked big financial turnaroundArkansas system's payer strategy sparked big financial turnaround
beckershospitalreview.com - April 23 at 7:05 PM
Oregon hospital plans layoffs amid RCM outsourcingOregon hospital plans layoffs amid RCM outsourcing
beckershospitalreview.com - April 23 at 7:05 PM
Availity taps R1 RCM exec as chief product officerAvaility taps R1 RCM exec as chief product officer
beckershospitalreview.com - April 22 at 3:22 PM
New York governor reaches deal to keep SUNY Downstate openNew York governor reaches deal to keep SUNY Downstate open
beckershospitalreview.com - April 21 at 8:42 AM
Mirae Asset Global Investments Co. Ltd. Sells 77,218 Shares of R1 RCM Inc. (NASDAQ:RCM)Mirae Asset Global Investments Co. Ltd. Sells 77,218 Shares of R1 RCM Inc. (NASDAQ:RCM)
marketbeat.com - April 19 at 4:39 AM
R1 RCM names VP of physician revenue cycle operationsR1 RCM names VP of physician revenue cycle operations
beckershospitalreview.com - April 18 at 12:58 PM
Sit Down Stand Up Olympian SpecialSit Down Stand Up Olympian Special
bbc.co.uk - April 18 at 7:57 AM
R1 RCM Inc. (NASDAQ:RCM) Shares Acquired by Voss Capital LLCR1 RCM Inc. (NASDAQ:RCM) Shares Acquired by Voss Capital LLC
marketbeat.com - April 15 at 7:23 PM
R1 RCM (NASDAQ:RCM) Given "Overweight" Rating at Cantor FitzgeraldR1 RCM (NASDAQ:RCM) Given "Overweight" Rating at Cantor Fitzgerald
marketbeat.com - April 10 at 11:26 AM
EUR/USD holds above 1.0860, eyes on US CPI, ECB rate decisionEUR/USD holds above 1.0860, eyes on US CPI, ECB rate decision
fxstreet.com - April 9 at 3:37 AM
Vista takes Model N private for $1.25BVista takes Model N private for $1.25B
axios.com - April 8 at 5:36 PM
Guggenheim Cuts R1 RCM (NASDAQ:RCM) Price Target to $15.00Guggenheim Cuts R1 RCM (NASDAQ:RCM) Price Target to $15.00
marketbeat.com - April 5 at 11:11 AM
Surgical Notes names former R1 RCM exec CFOSurgical Notes names former R1 RCM exec CFO
beckershospitalreview.com - April 4 at 1:37 PM
Inbox Health Announces Appointment of Kent Ivanoff to Board of DirectorsInbox Health Announces Appointment of Kent Ivanoff to Board of Directors
finance.yahoo.com - April 4 at 8:37 AM
Capstreet-backed Surgical Notes Names Dominic Brignola as Chief Financial OfficerCapstreet-backed Surgical Notes Names Dominic Brignola as Chief Financial Officer
finance.yahoo.com - April 3 at 5:36 PM
Capstreet-backed Surgical Notes taps Brignola as CFOCapstreet-backed Surgical Notes taps Brignola as CFO
pehub.com - April 3 at 12:35 PM
Surgical Notes taps new CFOSurgical Notes taps new CFO
beckersasc.com - April 3 at 12:35 PM
R1 RCM to Release First Quarter 2024 Results on May 8, 2024R1 RCM to Release First Quarter 2024 Results on May 8, 2024
globenewswire.com - April 1 at 5:00 PM
10 RCM headlines to know from March10 RCM headlines to know from March
beckershospitalreview.com - April 1 at 2:54 PM
Truist Financial Reaffirms Their Hold Rating on R1 RCM (RCM)Truist Financial Reaffirms Their Hold Rating on R1 RCM (RCM)
markets.businessinsider.com - April 1 at 2:54 PM
Truist Financial Reiterates Hold Rating for R1 RCM (NASDAQ:RCM)Truist Financial Reiterates Hold Rating for R1 RCM (NASDAQ:RCM)
marketbeat.com - April 1 at 9:10 AM
R1 RCM Inc. (NASDAQ:RCM) Short Interest UpdateR1 RCM Inc. (NASDAQ:RCM) Short Interest Update
marketbeat.com - March 29 at 8:18 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Genpact logo

Genpact

NYSE:G
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims. The Consumer and Healthcare segment provides demand generation, sensing and planning, supply chain planning and management, pricing and trade promotion management, deduction recovery management, order management, and digital commerce; and end-to-end claim lifecycle management, from claims processing and adjudication to claims recovery and payment integrity, revenue cycle management, health equity analytics, and care services. The High Tech and Manufacturing segment offers industry-specific solutions for trust and safety, advertising sales support, customer and user experience, and customer care support; and direct and indirect procurement, logistics, field, aftermarket support, and engineering services. It also provides digital operation services; data-tech-Al services; finance and accounting services, such as accounts payable, invoice-to-cash, record to report, financial planning and analysis, and enterprise risk and compliance; CFO advisory services; supply chain, and sourcing and procurement services; sales and commercial, and marketing and experience services; and environmental, social and governance services. The company was founded in 1997 and is based in Hamilton, Bermuda.
Lumen Technologies logo

Lumen Technologies

NYSE:LUMN
Lumen Technologies, Inc., a facilities-based technology and communications company, provides various integrated products and services to business and residential customers in the United States and internationally. The company operates in two segments, Business and Mass Markets. It offers dark fiber, edge cloud services, internet protocol, managed security, software-defined wide area networks, secure access service edge, unified communications and collaboration, and optical wavelengths services; ethernet and VPN data networks services; and legacy services to manage cash flow, including time division multiplexing voice, private line, and other legacy services, as well as sells communication equipment, and IT solutions. The company also provides high speed and lower speed broadband service to residential and small business customers; local and long-distance voice services, professional services, and other ancillary services; and federal broadband and state support programs. It serves its products and services under the Lumen, Quantum Fiber, and CenturyLink brands. The company was formerly known as CenturyLink, Inc. and changed its name to Lumen Technologies, Inc. in September 2020. Lumen Technologies, Inc. was incorporated in 1968 and is headquartered in Monroe, Louisiana.
R1 RCM logo

R1 RCM

NASDAQ:RCM
R1 RCM Inc. provides technology-driven solutions for the financial performance and patient experience of health systems, hospitals, and physician groups. It provides operating partnership/end-to-end solutions, which manages multiple aspects of the revenue cycle to realize financial leverage and revenue improvement for hospital and physician customers. The company also offers modular solutions, including functional partnership, an outsourcing solutions for improvements across targeted revenue cycle areas for hospital and physician group customers; revenue recovery, to fast-track payer and patient cash collections; revenue optimization, a solution to uncover missed or underreported revenue; clinical integrity, used to improve documentation and coding accuracy to maximize earned revenue for the services provided; and regulatory navigation, a compliance-first solutions for government reimbursement accuracy, pharmacy savings, and compliance. The company was incorporated in 2003 and is headquartered in Murray, Utah.